Clinic
Stat Med PC a California Medical Professional Corporation
Stat Med PC a California Medical Professional Corporation was paid $6.57M by Medicaid between Jan 2018 and Dec 2024, across 32 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.
33Billing provider infoSTAT MED PC A CALIFORNIA MEDICAL PROFESSIONAL CORPORATION
LAFAYETTE, CA 94549
LAFAYETTE, CA 94549
33aNPI1891132106assigned 05/28/2013
33bProvider typeUrgent Care Clinic/Center
28Total paid$6.57M
24GClaims57,669
24DCodes billed32
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in California
Rank by total paid#26 of 284
Median peer was paid$147K
This provider vs. median45×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,139 | $241K | |
| 2019 | 3,185 | $365K | |
| 2020 | 2,416 | $318K | |
| 2021 | 6,496 | $550K | |
| 2022 | 11,663 | $1.25M | |
| 2023 | 15,180 | $1.65M | |
| 2024incomplete | 16,590 | $2.20M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 14,947 | 14,487 | $2.39M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 34% | 11,148 | 11,043 | $2.24M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8.3% | 10,689 | 10,358 | $544K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 5.4% | 2,138 | 2,080 | $356K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 5.2% | 3,388 | 3,339 | $344K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.7% | 1,532 | 1,516 | $180K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.5% | 1,527 | 1,492 | $167K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.9% | 3,295 | 3,271 | $125K |
| 87631 | 1.5% | 581 | 579 | $99K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 438 | 328 | $22K |
| 87807 | <1% | 1,385 | 1,344 | $19K | |
| 87428 | <1% | 263 | 258 | $12K |
20 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 588 | $9K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 120 | $8K |
| 81003 | <1% | 2,988 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 341 | $7K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 207 | $6K |
| 81025 | <1% | 571 | $5K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 160 | $5K |
| 99205 | Prolong outpt/office vis | <1% | 15 | $5K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 220 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 167 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 141 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 31 | $1K |
| 99000 | <1% | 336 | $892.13 | |
| 0012A | <1% | 31 | $738.14 | |
| 0011A | <1% | 39 | $542.08 | |
| 0001A | <1% | 14 | $220.22 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 16 | $35.10 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 110 | $18.99 |
| 94760 | <1% | 230 | $3.92 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFINNANE, DANIEL (AUTHORIZED AGENT)